Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AffiliationNofer Institute of Occupational Medicine
MetadataShow full item record
AbstractBreast cancer (BC) is a major problem for civilization, manifested by continuously increasing morbidity and mortality among women worldwide. Core circadian genes may play an important role in cancer development and progression. To evaluate the effects of single nucleotide polymorphism (SNP) in circadian genes in BC risk, 16 functional SNPs were genotyped in 321 BC patients and 364 healthy women using the TaqMan fluorescence-labelled probes or High-Resolution Melt Curve technique in the Real-Time PCR system. The selected SNPs were analyzed for the risk of BC, progression, and the influence on gene expression in BC tissue pairs to demonstrate the functionality of genetic variants. The study showed a relationship between an increased BC risk under the dominant genetic model of CRY2 rs10838524, PER2 rs934945, and recessive genetic model of PER1 rs2735611. A protective effect of BMAL1 rs2279287 was observed among carriers with at least one variant allele. Moreover, we found an increased risk of estrogen-/progesterone-positive tumors under the dominant genetic model of PER2 rs934945 and estrogen negative tumors under the variant genotype of CRY2 rs10838524, PER1 rs2735611. We demonstrated significantly altered gene expression of BMAL1, CRY2, PER1, PER2, PER3 according to particular genotypes in the BC tissue pairs. Our findings support the hypothesized role of circadian genes in breast carcinogenesis and indicate probable biomarkers for breast cancer susceptibility.
CitationInt J Mol Sci. 2019 Nov; 20(22): 5704.
The following license files are associated with this item:
- Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.
- Authors: Lesicka M, Jabłońska E, Wieczorek E, Seroczyńska B, Siekierzycka A, Skokowski J, Kalinowski L, Wąsowicz W, Reszka E
- Issue date: 2018
- Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
- Authors: Marouf C, Göhler S, Filho MI, Hajji O, Hemminki K, Nadifi S, Försti A
- Issue date: 2016 Feb 26
- The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
- Authors: Dai H, Zhang L, Cao M, Song F, Zheng H, Zhu X, Wei Q, Zhang W, Chen K
- Issue date: 2011 Jun
- Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts.
- Authors: Zienolddiny S, Haugen A, Lie JA, Kjuus H, Anmarkrud KH, Kjærheim K
- Issue date: 2013
- The association between interleukin-1 polymorphisms and their protein expression in Chinese Han patients with breast cancer.
- Authors: Wang J, Shi Y, Wang G, Dong S, Yang D, Zuo X
- Issue date: 2019 Aug